Effect of Specific Surface Area and Hydrophobicity of Electrospun Nanofibers on the Sustained Release Performance of Diclofenac Sodium.

Nanofibers produced by electrospinning are suitable options for slow-release materials. Diclofenac sodium (DS) is a nonsteroidal anti-inflammatory medication with a brief half-life that can serve as an effective sustained-release agent. This paper presents a novel method for producing DS-sustained release nanofibers by electrostatic spinning processes. During the preparation, the slow-release capabilities of biodegradable materials poly(lactic acid) (PLA) and polycaprolactone (PCL) are investigated. A composite drug-carrying scaffold is prepared to enhance the sustained-release performance. The sustained release ability is affected by the specific surface area of the nanofibers and the hydrophobicity of the polymer. The findings indicate that the composite nanofiber with a PLA/PCL ratio of 1:1 demonstrates the most effective sustained-release performance. The release rate is mostly influenced by the hydrophobicity of the polymer at this point. Sustained-release kinetic simulations were performed and revealed that the release of nanofibers follows a first-order release paradigm. This work presents a straightforward approach for creating a sustained-release formulation of DS.

Effects of Reduction Methods on the Performance of Shewanella oneidensis MR-1 Palladium/Carbon Catalyst for Oxygen Reduction Reaction.

The influence of the reduction method on the morphology and performance of the catalyst still controversial. In this study, hydrogen, Shewanella oneidensis MR-1 (MR-1), MR-1 and hydrogen coreduction are used to reduce the palladium ions adsorbed by MR-1 to obtain Pd/CH2, Pd/CM, and Pd/CH2+M catalyst, respectively. It is found that the palladium nanoparticles (Pd NPs) in Pd/CH2+M are the largest, while the Pd NPs in Pd/CM are the smallest. This is due to the reduction of Pd NPs in Pd/CH2+M under anaerobic conditions to form smaller Pd NPs that will further aggregate and grow in H2. In addition, Pd/CM exhibited the best catalytic performance with a mass activity of 0.31 A mg-1, better than that of Pd/CH2 (0.06 A mg-1) and Pd/CH2+M (0.13 A mg-1). This study provides a meaningful reference for the selection of reduction methods in metal catalysts.

Preparation and Performance of a Cu@PtCu/CNF Oxygen Reduction Catalyst Membrane by Electrospinning.

A flexible carbon nanofiber film with high conductivity was prepared by electrospinning, and then Cu was uniformly deposited on the fiber film by pulse electrodeposition to prepare Cu nanocrystal/carbon nanofiber film. Cu@PtCu/carbon nanofiber (Cu@PtCu/CNF) catalytic films were synthesized by in-situ substitution reduction. The Cu@PtCu/CNF catalytic film solves the problem of uneven activity of the catalytic layer and can be directly used as the catalytic layer. The morphology and structure were characterized by transmission electron microscopy (TEM), scanning electron microscopy (SEM), X-ray diffraction (XRD), and X-ray photoelectron spectroscopy (XPS). Electrochemical test results show that the Cu@PtCu/CNF catalytic films obtained at the chloroplatinic acid concentration of 0.5 mg·mL-1 (N2) exhibited 2.5 times specific activity when compared with commercial Pt/C catalysts. After 5000 cycles of stability test, the electrochemical surface areas (ECSAs) were still maintained at 80%, and the half-wave potential decreased by 11 mV, which was better than those of commercial Pt/C catalysts.

Involvement of long non-coding RNAs in the pathogenesis of rheumatoid arthritis.

Long non-coding RNA (lncRNA) plays a contributory role in rheumatoid arthritis (RA). In this review, we summarized the current findings of lncRNAs in RA, including cellular function and the potential mechanisms. Serum lncRNA levels are associated with serum proinflammatory cytokines and disease activity. LncRNAs regulate proliferation, migration, invasion and apoptosis of RA fibroblast-like synoviocytes (FLSs), modulate the differentiation of T lymphocytes and macrophages, and affect bone formation-destruction balance of chondrocytes. Besides, lncRNAs are involved in inflammation and cell motivation signaling pathways. In-depth research on lncRNAs may help elucidate the pathogenesis of RA and provides clues for novel treatment targets.

Meta-Analysis of the Relationship between NM23 Expression to Gastric Cancer Risk and Clinical Features.

The prognostic value of reduced NM23 expression for gastric cancer (GC) patients is still contradictory. Thus, we conducted a meta-analysis to quantitatively evaluate the association of NM23 expression with GC risk and clinical features by analyzing 27 publications. The result of our meta-analysis indicated that NM23 expression is markedly reduced in gastric cancer tissues (OR = 3.15; 95% CI = 1.97-5.03; P < 0.001). Furthermore, NM23 expression was negatively correlated with N stage, TNM stage, and histological grade. However, NM23 expression was not correlated with T stage, lymphatic invasion, vascular invasion, and 5-year overall survival rate. In conclusion, reduced NM23 expression correlated with gastric cancer risk, but its association with GC clinical features remains inconclusive. Therefore, large-scale and well-designed studies, which use uniform antibody and criterion of NM23 positive expression, are required to further validate the role of the NM23 in predicting GC progression.